Article

AAO mourns Redmond's death

American Academy of Ophthalmology (AAO) past president Michael Redmond, MD, a pediatric ophthalmologist and pioneering advocate for the profession, died recently at his home in Florida, after a battle with cancer.

San Francisco-American Academy of Ophthalmology (AAO) past president Michael Redmond, MD, a pediatric ophthalmologist and pioneering advocate for the profession, died recently at his home in Florida, after a battle with cancer.

Dr. Redmond served on the AAO’s Board of Trustees from 1993 to 1999, first as chairman and vice chairman of the council and then as trustee-at-large. He was elected president in 2003.

“Mike Redmond’s passing is a loss for our entire profession,” said David W. Parke II, MD, academy chief executive officer and executive vice president. “He was a national leader for decades in the areas of professionalism, ethics, quality of care, advocacy, and practice management. One moment Mike was a busy practicing pediatric ophthalmologist; the next he was the physician-in-chief of a large multispecialty group; and the next he was an articulate and passionate member of the academy’s Ethics Committee. But above all, he was a compassionate, principled and thoroughly decent man. The profession of ophthalmology and all his family and friends will miss him deeply.”

For his extensive and tireless advocacy efforts on behalf of ophthalmology, Dr. Redmond received the AAO’s Outstanding Advocate Award in May. His close friend, Allan Jensen, MD, also a past president of the academy, presented the award at Dr. Redmond’s home.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.